Japan, Feb. 18 -- ACCELERON PHARMA INC has got intellectual property rights for 'TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2023-012757

Category (FI): A61K38/19,A61K47/64,A61K47/65,A61P1/16,A61P11/00,A61P13/12,A61P17/00,A61P37/02,A61P43/00,105,A61P7/00,A61P9/00,A61P9/04,A61P9/10,A61P9/10,101,C07K14/705,C07K16/00,C07K19/00,C12N15/12,C12N15/13,C12N15/62@Z,C12N5/10,C12P21/02@C

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 31, 2023

Publication Date: April 18, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....